Naci, Huseyin, Cylus, Jonathan, Vandoros, Sotiris, Sato, Azusa and Perampaladas , Kumar (2012) Raising the bar for market authorisation of new drugs. BMJ, 345 . e4261-e4261. ISSN 1756-1833
Huseyin Naci and colleagues find that raising evidence standards for market entry of new drugs could have numerous benefits, including providing incentives for development in therapeutic areas with few treatment options.
|Additional Information:||© 2012 BMJ Publishing Group Ltd.|
|Library of Congress subject classification:||R Medicine > RA Public aspects of medicine|
|Sets:||Research centres and groups > LSE Health and Social Care
Research centres and groups > LSE Health
Actions (login required)
|Record administration - authorised staff only|